Reports
Sale
North America Breast Implants Market Size, Share, Growth: By Type: Silicone Implants, Form-Stable Implants, Saline Implants, Structured Saline Implants, Others; By Implant Shape: Round, Anatomical, Others; By Application: Reconstructive Surgery, Cosmetic surgery, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032
North America Breast Implants Market Outlook
The North America breast implants market size was valued at USD 0.8 billion in 2023, driven by the growing demand for breast implants in reconstructive surgery for breast cancer survivors along with the rising innovation in breast implant technology in the region. The market is expected to grow at a CAGR of 5.13% during the forecast period of 2024-2032, with the value likely to reach USD 1.2 billion by 2032.
Key Takeaways
- According to the National Breast Cancer Foundation, Inc., around 1 in 8 women are estimated to be diagnosed with breast cancer in their lifetime in the United States. Further, it is predicted that 310,720 women will be diagnosed with invasive breast cancer in 2024.
- In October 2023, Establishment Labs Inc., announced that the FDA granted 510(k) clearance for the Motiva Flora® SmoothSilk® Tissue Expander, the first-ever magnet-free, and MR conditional breast tissue expander (which permits women to undergo MRI). Such approvals are poised to impact the North America breast implants market share positively in coming years.
- In June 2023, a growth capital investment was made in Olympus Cosmetic Group (a provider of cosmetic surgery in the United States), aimed at supporting the development of a physician-owned platform and help to provide premium outcomes to its patients.
The surge in the demand for breast augmentation procedures, attributed to aesthetic reasons along with the rising prevalence of breast cancer in the region is likely to boost the North America breast implants market growth in the forecast period. According to the National Breast Cancer Foundation, Inc., around 1 in 8 women are estimated to be diagnosed with breast cancer in their lifetime in the United States. In addition, it is predicted that 310,720 women will be diagnosed with invasive breast cancer in 2024. Thus, the rising cases of breast cancer coupled with the advancements in reconstructive surgery for breast cancer survivors are expected to fuel the market demand in the forecast period.
The improvement in regulatory policies by health authorities such as the United States Food and Drug Administration (FDA) is likely to propel market growth. The availability of innovative products in healthcare facilities is anticipated to positively influence North America breast implants market demand. In October 2023, Establishment Labs Inc., a global medical technology company specializing in Femtech solutions for breast health, breast aesthetics, and breast reconstruction, announced that the FDA granted 510(k) clearance for the Motiva Flora® SmoothSilk® Tissue Expander. Titled as the first-ever magnet-free, and MR conditional breast tissue expander (which permits women to undergo magnetic resonance imaging (MRI)), its application has been approved in the United States market. Compared to other implant surfaces, SmoothSilk® has shown to exhibit minimum foreign body response and inflammation.
One of the significant North America breast implants market trends is the increased investment in the aesthetic surgery sector in order to meet the growing demand for breast augmentation and reconstruction procedures. In June 2023, a growth capital investment was made in Olympus Cosmetic Group (a provider of cosmetic surgery including breast augmentation and cosmetic dermatology procedures in the United States) by VSS Capital Partners, a New York-based private equity firm known for its investment in healthcare. The investment will support the development of this physician-owned platform and help to provide premium outcomes to its patients. Further, these investments also ensure the availability of skilled professionals and high-quality services, which is expected to bolster market growth in the region.
Other factors that impact the market landscape include the rise in technological innovation in breast implant technology, increasing economic growth, and growing disposable incomes in North America which allow more individuals to afford the cosmetic procedure.
North America Breast Implants Market Segmentation
North America breast implants market analysis offers a detailed breakup of the market based on the following segments:
| Market Breakup | Categories |
| Type | Silicone Implants, Form-Stable Implants, Saline Implants, Structured Saline Implants, Others |
| Implant Shape | Round, Anatomical, Others |
| Application | Reconstructive Surgery, Cosmetic Surgery, Others |
| End User | Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers, Others |
| Countries | United States of America, Canada |
North America Breast Implants Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Establishment Labs SA
- GC Aesthetics
- Groupe Sebbin SAS
- Laboratories Arion
- Silimed
- Johnson & Johnson (Mentor Worldwide LLC)
- HansBioMed
- Cereplas
- Sientra Inc.
- AbbVie Inc. (Allergan PLC)
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Implant Shape |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 North America Breast Implants Market Overview
3.1 North America Breast Implants Market Historical Value (2017-2023)
3.2 North America Breast Implants Market Forecast Value (2024-2032)
4 North America Breast Implants Market Landscape*
4.1 North America Breast Implants: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 North America Breast Implants: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Implant Shape
5 North America Breast Implants Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 North America Breast Implants Market Segmentation (2017-2032)
6.1 North America Breast Implants Market (2017-2032) by Type
6.1.1 Market Overview
6.1.2 Silicone Implants
6.1.3 Form-Stable Implants
6.1.4 Saline Implants
6.1.5 Structured Saline Implants
6.1.6 Others
6.2 North America Breast Implants Market (2017-2032) by Implant Shape
6.2.1 Market Overview
6.2.2 Round
6.2.3 Anatomical
6.2.4 Others
6.3 North America Breast Implants Market (2017-2032) by Application
6.3.1 Market Overview
6.3.2 Reconstructive Surgery
6.3.3 Cosmetic surgery
6.3.4 Others
6.4 North America Breast Implants Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Cosmetology Clinics
6.4.4 Ambulatory Surgical Centers
6.4.5 Others
6.5 North America Breast Implants Market (2017-2032) by Countries
6.5.1 Market Overview
6.5.2 United States of America
6.5.3 Canada
7 United States of America Breast Implants Market (2017-2032)
7.1 United States of America Breast Implants Market (2017-2032) by Type
7.1.1 Market Overview
7.1.2 Silicone Implants
7.1.3 Form-Stable Implants
7.1.4 Saline Implants
7.1.5 Structured Saline Implants
7.1.6 Others
7.2 United States of America Breast Implants Market (2017-2032) by Implant Shape
7.2.1 Market Overview
7.2.2 Round
7.2.3 Anatomical
7.2.4 Others
7.3 United States of America Breast Implants Market (2017-2032) by Application
7.3.1 Market Overview
7.3.2 Reconstructive Surgery
7.3.3 Cosmetic surgery
7.3.4 Others
7.4 United State of America Breast Implants Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Hospitals
7.4.3 Cosmetology Clinics
7.4.4 Ambulatory Surgical Centers
7.4.5 Others
8 Canada Breast Implants Market (2017-2032)
8.1 Canada Breast Implants Market (2017-2032) by Type
8.1.1 Market Overview
8.1.2 Silicone Implants
8.1.3 Form-Stable Implants
8.1.4 Saline Implants
8.1.5 Structured Saline Implants
8.1.6 Others
8.2 Canada Breast Implants Market (2017-2032) by Implant Shape
8.2.1 Market Overview
8.2.2 Round
8.2.3 Anatomical
8.2.4 Others
8.3 Canada Breast Implants Market (2017-2032) by Application
8.3.1 Market Overview
8.3.2 Reconstructive Surgery
8.3.3 Cosmetic surgery
8.3.4 Others
8.4 Canada Breast Implants Market (2017-2032) by End User
8.4.1 Market Overview
8.4.2 Hospitals
8.4.3 Cosmetology Clinics
8.4.4 Ambulatory Surgical Centers
8.4.5 Others
9 Regulatory Framework
10 Patent Analysis
10.1 Analysis by Type of Patent
10.2 Analysis by Publication year
10.3 Analysis by Issuing Authority
10.4 Analysis by Patent Age
10.5 Analysis by CPC Analysis
10.6 Analysis by Patent Valuation
10.7 Analysis by Key Players
11 Funding and Investment Analysis
11.1 Analysis by Funding Instances
11.2 Analysis by Type of Funding
11.3 Analysis by Funding Amount
11.4 Analysis by Leading Players
11.5 Analysis by Leading Investors
11.6 Analysis by Geography
12 Partnership and Collaborations Analysis
12.1 Analysis by Partnership Instances
12.2 Analysis by Type of Partnership
12.3 Analysis by Leading Players
12.4 Analysis by Geography
13 Supplier Landscape
13.1 Market Share by Top 5 Companies
13.2 Establishment Labs SA
13.2.1 Financial Analysis
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Mergers and Acquisitions
13.2.5 Certifications
13.3 GC Aesthetics
13.3.1 Financial Analysis
13.3.2 Product Portfolio
13.3.3 Demographic Reach and Achievements
13.3.4 Mergers and Acquisitions
13.3.5 Certifications
13.4 Groupe Sebbin SAS
13.4.1 Financial Analysis
13.4.2 Product Portfolio
13.4.3 Demographic Reach and Achievements
13.4.4 Mergers and Acquisitions
13.4.5 Certifications
13.5 Laboratories Arion
13.5.1 Financial Analysis
13.5.2 Product Portfolio
13.5.3 Demographic Reach and Achievements
13.5.4 Mergers and Acquisitions
13.5.5 Certifications
13.6 Silimed
13.6.1 Financial Analysis
13.6.2 Product Portfolio
13.6.3 Demographic Reach and Achievements
13.6.4 Mergers and Acquisitions
13.6.5 Certifications
13.7 Johnson & Johnson (Mentor Worldwide LLC)
13.7.1 Financial Analysis
13.7.2 Product Portfolio
13.7.3 Demographic Reach and Achievements
13.7.4 Mergers and Acquisitions
13.7.5 Certifications
13.8 HansBioMed
13.8.1 Financial Analysis
13.8.2 Product Portfolio
13.8.3 Demographic Reach and Achievements
13.8.4 Mergers and Acquisitions
13.8.5 Certifications
13.9 Cereplas
13.9.1 Financial Analysis
13.9.2 Product Portfolio
13.9.3 Demographic Reach and Achievements
13.9.4 Mergers and Acquisitions
13.9.5 Certifications
13.10 Sientra Inc.
13.10.1 Financial Analysis
13.10.2 Product Portfolio
13.10.3 Demographic Reach and Achievements
13.10.4 Mergers and Acquisitions
13.10.5 Certifications
13.11 AbbVie Inc. (Allergan PLC)
13.11.1 Financial Analysis
13.11.2 Product Portfolio
13.11.3 Demographic Reach and Achievements
13.11.4 Mergers and Acquisitions
13.11.5 Certifications
14 North America Breast Implants Market – Distribution Model (Additional Insight)
14.1 Overview
14.2 Potential Distributors
14.3 Key Parameters for Distribution Partner Assessment
15 Key Opinion Leaders (KOL) Insights (Additional Insight)
16 Company Competitiveness Analysis (Additional Insight)
16.1 Very Small Companies
16.2 Small Companies
16.3 Mid-Sized Companies
16.4 Large Companies
16.5 Very Large Companies
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market attained a value of about USD 0.8 billion in 2023, driven by the growing demand for breast implants in reconstructive surgery for breast cancer survivors in the region.
The market is anticipated to grow at a CAGR of 5.13% during the forecast period of 2024-2032, likely to reach a market value of USD 1.2 billion by 2032.
The growing prevalence of breast cancer and the rising disposable income in the region are fuelling the demand for the market.
One of the significant trends in the market is the improvement in regulatory policies by health agencies such as the United States Food and Drug Administration (FDA). In October 2023 , Establishment Labs Inc., a global medical technology company, announced that the FDA granted 510(k) clearance for the Motiva Flora® SmoothSilk® Tissue Expander, the first-ever magnet-free, and MR conditional breast tissue expander (which permits women to undergo magnetic resonance imaging (MRI)) approved for the United States market.
By type, the market is divided into silicone implants, form-stable implants, saline implants, and structured saline implants, among others.
The market breakup by implant shape includes round and anatomical, among others.
End users of the market are hospitals, cosmetology clinics, and ambulatory surgical centers, among others.
Major applications areas of breast implants include reconstructive surgery, and cosmetic surgery, among others.
The market segmentation by countries includes the United States of America and Canada.
The key players in the market are Establishment Labs SA, GC Aesthetics, Groupe Sebbin SAS, Laboratories Arion, Silimed, Johnson & Johnson (Mentor Worldwide LLC), HansBioMed, Cereplas, Sientra Inc., and AbbVie Inc. (Allergan PLC).
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER